Dario A. Paggiarino

813 total citations
22 papers, 647 citations indexed

About

Dario A. Paggiarino is a scholar working on Ophthalmology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Dario A. Paggiarino has authored 22 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Dario A. Paggiarino's work include Retinal Diseases and Treatments (7 papers), Retinal and Optic Conditions (7 papers) and Ocular Diseases and Behçet’s Syndrome (6 papers). Dario A. Paggiarino is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Retinal and Optic Conditions (7 papers) and Ocular Diseases and Behçet’s Syndrome (6 papers). Dario A. Paggiarino collaborates with scholars based in United States, Israel and Canada. Dario A. Paggiarino's co-authors include Sol Silverman, Francis G. LeVeque, Peter B. Lockhart, Joel B. Epstein, Michael J. Gallagher, Neil Senzer, Mark M. Schubert, S. Crockett, Quan Dong Nguyen and Irit Rosenblatt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Ophthalmology.

In The Last Decade

Dario A. Paggiarino

22 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dario A. Paggiarino United States 10 241 208 206 147 131 22 647
Ioana Molnar France 13 117 0.5× 167 0.8× 83 0.4× 27 0.2× 132 1.0× 55 508
Jennifer D. Davidson United States 9 146 0.6× 106 0.5× 143 0.7× 8 0.1× 155 1.2× 17 477
Panos Goumas Greece 13 99 0.4× 65 0.3× 31 0.2× 75 0.5× 86 0.7× 26 368
Masato Kita Japan 16 166 0.7× 92 0.4× 288 1.4× 6 0.0× 43 0.3× 55 853
María A. Saornil Spain 18 207 0.9× 44 0.2× 558 2.7× 5 0.0× 152 1.2× 55 777
H. Moses United States 6 362 1.5× 138 0.7× 29 0.1× 15 0.1× 207 1.6× 8 692
Susana Esteves Portugal 11 83 0.3× 58 0.3× 7 0.0× 38 0.3× 133 1.0× 49 442
Mihoko Shibuya Japan 10 82 0.3× 52 0.3× 29 0.1× 10 0.1× 110 0.8× 15 494
Mostafa Hanout United States 14 130 0.5× 40 0.2× 581 2.8× 8 0.1× 23 0.2× 34 706
Geneviève Coulombe Canada 14 131 0.5× 102 0.5× 4 0.0× 126 0.9× 180 1.4× 29 537

Countries citing papers authored by Dario A. Paggiarino

Since Specialization
Citations

This map shows the geographic impact of Dario A. Paggiarino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario A. Paggiarino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario A. Paggiarino more than expected).

Fields of papers citing papers by Dario A. Paggiarino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario A. Paggiarino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario A. Paggiarino. The network helps show where Dario A. Paggiarino may publish in the future.

Co-authorship network of co-authors of Dario A. Paggiarino

This figure shows the co-authorship network connecting the top 25 collaborators of Dario A. Paggiarino. A scholar is included among the top collaborators of Dario A. Paggiarino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario A. Paggiarino. Dario A. Paggiarino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Sunil, Philip Storey, Mark Barakat, et al.. (2024). Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration. Ophthalmology Science. 4(5). 100527–100527. 6 indexed citations
2.
Bacharach, Jason, Mitchell Jackson, Inder Paul Singh, et al.. (2022). First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract Surgery. Clinical ophthalmology. Volume 16. 1783–1794. 3 indexed citations
3.
Singer, Michael, et al.. (2021). IOP Elevation in Patients Treated With Fluocinolone Acetonide Insert for Chronic Noninfectious Uveitis Affecting the Posterior Segment. Ophthalmic surgery, lasers & imaging retina. 52(7). 387–390. 2 indexed citations
4.
Matossian, Cynthia, John Hovanesian, Jason Bacharach, Dario A. Paggiarino, & Keyur Patel. (2020). Impact of dexamethasone intraocular suspension 9% on intraocular pressure after routine cataract surgery: post hoc analysis. Journal of Cataract & Refractive Surgery. 47(1). 53–64. 7 indexed citations
5.
Nguyen, Quan Dong, et al.. (2019). Minimizing Recurrences of Ocular Inflammation and Need for Adjunctive Treatment of Non-infectious Posterior Uveitis (NIPU) during the 2 Years Following Treatment with a Single 0.18 mg Fluocinolone Acetonide Intravitreal Insert (FAi). Investigative Ophthalmology & Visual Science. 60(9). 3513–3513. 2 indexed citations
6.
Nguyen, Quan Dong, Keyur Patel, & Dario A. Paggiarino. (2018). Controlling Posterior Segment Uveitic Recurrences: Results from a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Intravitreal Insert (FAi) in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment. Investigative Ophthalmology & Visual Science. 59(9). 418–418. 2 indexed citations
7.
Jaffe, Glenn J., C. Stephen Foster, Carlos Pavésio, Dario A. Paggiarino, & Gerard E. Riedel. (2018). Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment. Ophthalmology. 126(4). 601–610. 73 indexed citations
8.
Jaffe, Glenn J., et al.. (2017). An Injectable Fluocinolone Acetonide Intravitreal Insert Decreases the Incidence of Recurrence in Patients with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye: 12 Month Results. Investigative Ophthalmology & Visual Science. 58(8). 1232–1232. 2 indexed citations
9.
Bhatt, Rupal S., Sumanta K. Pal, Harry A. Drabkin, et al.. (2014). A multicenter, open-label, single-arm, phase 2 study of the S1P inhibitor sonepcizumab (LT1009) in patients with previously treated metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 32(15_suppl). TPS4605–TPS4605. 1 indexed citations
10.
Nguyen, Quan Dong, Ronald A. Schachar, Chudy I. Nduaka, et al.. (2012). Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study). Ophthalmology. 119(9). 1867–1873. 70 indexed citations
11.
Nguyen, Quan Dong, Ronald A. Schachar, Chudy I. Nduaka, et al.. (2012). Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients. Eye. 26(8). 1099–1105. 61 indexed citations
12.
Goldberg, Ivan, et al.. (2008). A 5-year, Randomized, Open-Label Safety Study of Latanoprost and Usual Care in Patients with Open-Angle Glaucoma or Ocular Hypertension. European Journal of Ophthalmology. 18(3). 408–416. 28 indexed citations
13.
Bosworth, Charles, et al.. (2006). Comparison of Eyedrop Delivery Using Either a Novel Horizontal Delivery Device or a Conventional Dropper Bottle. Investigative Ophthalmology & Visual Science. 47(13). 456–456. 1 indexed citations
14.
Epstein, Joel B., Sol Silverman, Dario A. Paggiarino, et al.. (2001). Benzydamine HCl for prophylaxis of radiation-induced oral mucositis. Cancer. 92(4). 875–885. 201 indexed citations
15.
Bartlett, Jimmy D., et al.. (1997). Dose-Response Study of Dapiprazole HCl in the Reversal of Mydriasis Induced by 2.5% Phenylephrine. Journal of Ocular Pharmacology and Therapeutics. 13(4). 297–302. 4 indexed citations
16.
Schachtel, Bernard & Dario A. Paggiarino. (1996). A Randomized, Double-Blind, Placebo-Controlled Model Demonstrating the Topical Effect of Benzydamine in Children with Sore Throat. Clinical Pharmacology & Therapeutics. 59(2). 146–146. 7 indexed citations
17.
Scarantino, Charles W., et al.. (1994). A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 29(5). 999–1004. 14 indexed citations
18.
Paggiarino, Dario A., et al.. (1993). The effects on pupil size and accommodation of sympathetic and parasympatholytic agents.. PubMed. 25(7). 244–9, 253. 13 indexed citations
19.
Scarantino, Charles W., et al.. (1991). Lonidamine in head and neck cancer: an overview.. PubMed. 18(2 Suppl 4). 28–32. 3 indexed citations
20.
Gaudio, Eugenio, Dario A. Paggiarino, & F. Carpino. (1984). Structural and Ultrastructural Modifications of Cryptorchid Human Testes. The Journal of Urology. 131(2). 292–296. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026